What is CINRYZE?

Not real patients.

CINRYZE Dosing and Administration1

CINRYZE for prevention of HAE attacks can be self-administered by the patient or administered by a caregiver or a healthcare provider. Talk with your patient and/or their caregiver to determine what administration option will work best for them.

Patients whose CINRYZE lot number matches one of the eight lot numbers shown in red text below should follow the instructions shown in this booklet.

  • 17F19L370A, 17F24L370A, 17G10L370A, 17G16L370A, 17G21L370A, 17H12L370A, 17G26L370A and 17H22L370A.

Dosing of CINRYZE
 
  Adults and teenagers (≥12 years)1 Children (6 to 11 years)1
Dose
1,000 U intravenous
For patients who have not responded adequately to 1,000 U, doses up to 2,500 U (not exceeding 100 U/kg) may be considered based on individual response
500 U intravenous
The dose may be adjusted according to individual response, up to 1,000 U
Dosing regimen Administered every 3 or 4 days
Infusion rate 1 mL/min (10 minutes) 1 mL/min (5 minutes)

The Mix2Vial® transfer device is a needle-free reconstitution and transfer system to facilitate reconstitution and administration.

Would you like a copy of the CINRYZE preparation and self-administration guide for your patients?

Download PDF

Preparation and handling

  • CINRYZE should not be frozen, and it should be stored in its original carton to protect the active ingredient from light
  • Once reconstituted, the solution must be used within 3 hours
  • As supplied, CINRYZE is stable for the period stated on the vial and carton label at 2°C to 25°C (36°F to 77°F); check the expiration date prior to reconstitution

Keep patients on track

As you work with your HAE patients to create individualized treatment plans, you can help support compliance with CINRYZE. Consider the following approach:

  • Set up a treatment schedule to keep patients on track
  • Empower your patients to take charge by following the infusion schedule you provide
  • Remind patients about the benefits of staying compliant. Even if they are experiencing fewer or no attacks, missing a dose of CINRYZE can result in breakthrough attacks

Help patients stay on track with self-administration training.

Explore the program

You might also be interested in:

Reference

  1. CINRYZE® (C1 esterase inhibitor [human]) Prescribing Information. Shire.

Definition: